utibron neohaler

Frequently asked questions

How is Utibron Neohaler rated?

pharmaranks gives Utibron Neohaler a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.

How much does Utibron Neohaler cost?

Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $0.22 per ml, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.

Is there a coupon or discount for Utibron Neohaler?

pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Utibron Neohaler. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.

Who makes Utibron Neohaler?

Utibron Neohaler is marketed by Novartis. You can see Novartis's full profile, rating, and other products on pharmaranks.

Is Utibron Neohaler a brand-name or generic drug?

Utibron Neohaler is a brand-name product with the active ingredient Glycopyrrolate and Indacaterol Maleate.

Is Utibron Neohaler available over the counter?

No. Utibron Neohaler is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.

What forms does Utibron Neohaler come in?

Utibron Neohaler is currently marketed as powder, per the FDA's National Drug Code Directory.

Is Utibron Neohaler FDA-registered?

Utibron Neohaler is on record with the U.S. FDA under application number NDA207930. You can verify this on its official FDA label.

Has Utibron Neohaler been recalled by the FDA?

Utibron Neohaler has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.

Is Utibron Neohaler safe?

There's no single safe-or-not verdict. pharmaranks gives Utibron Neohaler a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.